Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
39
TGEN Quote, Financials, Valuation and Earnings
Last price:
$5.78
Seasonality move
:
-5.35%
Day range:
$5.92 - $6.44
52-week range:
$0.68 - $9.38
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.38x
P/B ratio:
15.92x
Volume:
1.2M
Avg. volume:
551.8K
1-year change:
669.43%
Market cap:
$153.6M
Revenue:
$22.6M
EPS (TTM):
-$0.18
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Tecogen has -25.99% downside to fair value with a price target of -- per share.
TGEN vs. S&P 500
-
Over the past 5 trading days, Tecogen has underperformed the S&P 500 by -30.4% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Tecogen does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Tecogen has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Tecogen reported revenues of $7.3M.
Earnings Growth
-
Tecogen earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Tecogen reported earnings per share of -$0.03.
Enterprise value:
150.9M
EV / Invested capital:
--
Price / LTM sales:
6.38x
EV / EBIT:
--
EV / Revenue:
6.37x
PEG ratio (5yr expected):
-2.70x
EV / Free cash flow:
91.88x
Price / Operating cash flow:
92.11x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$10.5M
Return On Assets:
-14.99%
Net Income Margin (TTM):
-18.2%
Return On Equity:
-38.16%
Return On Invested Capital:
-34.63%
Operating Margin:
-8.17%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $22.9M | $25.9M | $23.7M | $6.2M | $7.3M | |
| Gross Profit | $10.1M | $10.7M | $10.5M | $2.6M | $3.2M | |
| Operating Income | -$3.8M | -$4.1M | -$3.9M | -$1.1M | -$594.2K | |
| EBITDA | -$3.5M | -$3.4M | -$3.5M | -$906.8K | -$441.5K | |
| Diluted EPS | -$0.16 | -$0.16 | -$0.18 | -$0.04 | -$0.03 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $23.3M | $25.6M | $22.4M | $19.7M | $20.6M | |
| Total Assets | $31.6M | $32.8M | $28.2M | $28.5M | $29.7M | |
| Current Liabilities | $7.2M | $9.3M | $9.4M | $11.2M | $14.9M | |
| Total Liabilities | $12.5M | $11.5M | $10.7M | $14.8M | $20.2M | |
| Total Equity | $19.1M | $21.3M | $17.6M | $13.6M | $9.5M | |
| Total Debt | $1.9M | -- | -- | $511.9K | $1.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$3.5M | -$284.7K | $2.6M | $248.2K | -$1.2M | |
| Cash From Investing | -$300.5K | -$316.8K | -$1.1M | -$71.9K | -$164.9K | |
| Cash From Financing | -- | $482.9K | $1M | -$17.1K | -$130 | |
| Free Cash Flow | -$3.8M | -$436.5K | $1.6M | $143.3K | -$1.3M | |
TGEN
Sector
Market Cap
$153.6M
$611.3M
Price % of 52-Week High
64.82%
81.21%
Dividend Yield
0%
0%
Shareholder Yield
--
2.28%
1-Year Price Total Return
669.43%
-1.12%
Beta (5-Year)
0.990
0.761
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$7.64
200-day SMA
Buy
Level
$2.76
Bollinger Bands (100)
Buy
Level
1.8 - 6.08
Chaikin Money Flow
Sell
Level
-1.7M
20-day SMA
Sell
Level
$7.35
Relative Strength Index (RSI14)
Sell
Level
43.82
ADX Line
Sell
Level
21.26
Williams %R
Buy
Level
-95.3757
50-day SMA
Buy
Level
$5.72
MACD (12, 26)
Buy
Level
1.92
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Sell
Level
-3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.6471)
Sell
CA Score
(Annual)
Level (-1.206)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (3.6626)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (6)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Tecogen Inc, designs, manufactures, markets, and maintains high-efficiency, ultra-clean cogeneration products. It operates in three business segments, namely Products, Services, and Energy Production. Products segment designs, manufactures, and sells industrial and commercial cogeneration systems. The services segment provides operations and maintenance services and turn-key installation for products under long-term service contracts. The Energy Production segment sells energy in the form of electricity, heat, hot water, and cooling to the customers under long-term energy sales agreements.
Stock Forecast FAQ
In the current month, TGEN has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The TGEN average analyst price target in the past 3 months is --.
-
Where Will Tecogen Stock Be In 1 Year?
According to analysts, the consensus estimate is that Tecogen share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Tecogen?
Analysts are divided on their view about Tecogen share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Tecogen is a Sell and believe this share price will rise from its current level to --.
-
What Is Tecogen's Price Target?
The price target for Tecogen over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is TGEN A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Tecogen is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of TGEN?
You can purchase shares of Tecogen via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Tecogen shares.
-
What Is The Tecogen Share Price Today?
Tecogen was last trading at $5.78 per share. This represents the most recent stock quote for Tecogen. Yesterday, Tecogen closed at $6.08 per share.
-
How To Buy Tecogen Stock Online?
In order to purchase Tecogen stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
